D.E. Shaw & Co’s Aehr Test Systems AEHR Stock Holding History

D.E. Shaw & Co’s Portfolio AEHR Stock Details AEHR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$3.04M	Sell	82,000 -289,900	-78%	-$9.27M	﹤0.01%	2582
2025 Q4	$7.51M	Buy	371,900 +6,300	+2%	+$152K	﹤0.01%	1993
2025 Q3	$11M	Buy	365,600 +270,600	+285%	+$5.86M	0.01%	1602
2025 Q2	$1.23M	Buy	95,000 +65,000	+217%	+$619K	﹤0.01%	3094
2025 Q1	$219K	Sell	30,000 -32,900	-52%	-$364K	﹤0.01%	3901
2024 Q4	$1.05M	Hold	62,900	–	–	﹤0.01%	3183
2024 Q3	$808K	Hold	62,900	–	–	﹤0.01%	3416
2024 Q2	$703K	Buy	62,900 +30,000	+91%	+$350K	﹤0.01%	3411
2024 Q1	$408K	Buy	+32,900	New	+$548K	﹤0.01%	3585

Other funds holding AEHR

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

AIC

AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

NCGI

Next Century Growth Investors Plymouth, Minnesota $1.38B AUM 102.34% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

D.E. Shaw & Co's AEHR Position: Q1 2026 in Review

D.E. Shaw & Co increased its Aehr Test Systems (AEHR) stake by 18% in Q1 2026, buying an estimated $1.64M and bringing the position to 341,638 shares worth $12.7M. The position accounts for 0.01% of the portfolio, ranked #1440.

D.E. Shaw & Co first reported a position in AEHR in Q1 2022 and has held it in 9 quarters since. The position peaked at $24.6M in Q2 2023. 191 funds tracked by Wall St. Rank hold AEHR as of Q1 2026.

D.E. Shaw & Co held 341,638 shares of Aehr Test Systems worth $12.7M as of Q1 2026.
D.E. Shaw & Co bought 51,347 Aehr Test Systems shares in Q1 2026, an estimated $1.64M.
Aehr Test Systems made up 0.01% of D.E. Shaw & Co's portfolio in Q1 2026, its #1440 holding.
D.E. Shaw & Co first reported a position in Aehr Test Systems in Q1 2022 and has held it in 9 quarters since.
D.E. Shaw & Co's Aehr Test Systems position peaked at $24.6M in Q2 2023.
191 funds tracked by Wall St. Rank held Aehr Test Systems as of Q1 2026.

Based on D.E. Shaw & Co's 13F filing for Q1 2026, filed 15 May 2026.